Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392247 · ClinicalTrials.gov registry record
Hemosonics- VCU Cardiac Surgery Clinical Study
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 52
- Enrollment target
NCT02392247 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 52 participants.
The verdict
NCT02392247 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.
Interventions
- DEVICE Coagulation function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02392247
The ClinicalTrials.gov registry entry for NCT02392247 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coagulation function is the first listed.
NCT02392247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02392247 about?
NCT02392247 is a clinical study titled "Hemosonics- VCU Cardiac Surgery Clinical Study". This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.
What is the current status of trial NCT02392247?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2015-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02392247?
The interventions under investigation include: Coagulation function (DEVICE).
Who is sponsoring clinical trial NCT02392247?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.